CC BY-NC-ND 4.0 · Indian J Radiol Imaging 2016; 26(01): 73-80
DOI: 10.4103/0971-3026.178340
Intervention Radiology

Outcomes of catheter-directed treatment of lower extremity deep vein thrombosis of patients presenting to a tertiary care hospital

Gaurav Sundar
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India
,
Shyamkumar N Keshava
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India
,
Vinu Moses
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India
,
George K Chiramel
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India
,
Munawwar Ahmed
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India
,
Suraj Mammen
Department of Radiology, Christian Medical College, Vellore, Tamil Nadu, India
,
Sunil Aggarwal
Department of Vascular Surgery, Christian Medical College, Vellore, Tamil Nadu, India
,
Edwin Stephen
Department of Vascular Surgery, Christian Medical College, Vellore, Tamil Nadu, India
› Author Affiliations
Financial support and sponsorship Nil.

Abstract

Background: Lower extremity deep vein thrombosis (DVT) is a common illness with an annual incidence of 1 per 1000 adults. The major long-term complication of DVT is post-thrombotic syndrome (PTS) which occurs in up to 60% of patients within 2 years of an episode of DVT. Aims: We aim to evaluate the outcomes of catheter-directed treatment (CDT) for symptomatic acute or subacute lower extremity DVT. Materials and Methods: A retrospective 12-year study was conducted on the outcomes of CDT on 54 consecutive patients who presented with acute or subacute lower extremity DVT to our hospital. Statistical Analysis: Descriptive summary statistics and the Chi-square test were used to measure the outcomes of CDT. Results: Grade 3 thrombolysis was achieved in 25 (46.3%) patients, grade 2 thrombolysis in 25 (46.3%) patients, and grade 1 thrombolysis in 4 (7.4%) patients. Significant recanalization (grade 2 or 3 thrombolysis) was possible in 50 (92.6%) patients. There was no statistically significant difference in the percentage of significant recanalization that could be achieved between patients who underwent CDT before and after 10 days. There was no significant difference between the thrombolysis achieved between urokinase and r-tPA. PTS was seen in 33% of the patients. Major complications were seen in 5.5% of the patients. Conclusion: CDT is a safe and effective therapeutic technique in patients with acute and subacute lower extremity DVT, if appropriate patient selection is made.



Publication History

Article published online:
30 July 2021

© 2016. Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

 
  • References

  • 1 White RH. The epidemiology of venous thromboembolism. Circulation 2003;107 23 Suppl 1:I4-8.
  • 2 Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126 3 Suppl: 401S-28S.
  • 3 Brandjes DP, Büller HR, Heijboer H, Huisman MV, de Rijk M, Jagt H, et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997;349:759-62.
  • 4 Watson L, Broderick C, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2014;1:CD002783.
  • 5 Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: Report of a national multicenter registry. Radiology 1999;211:39-49.
  • 6 Sousa Nanji L, Torres Cardoso A, Costa J, Vaz-Carneiro A. Analysis of the cochrane review: Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst Rev 2014;1:CD002783. Acta Med Port Jan-Feb 2015;28 (1):12-14.
  • 7 Enden T, Kløw NE, Sandvik L, Slagsvold CE, Ghanima W, Hafsahl G, et al. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: Results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 2009;7:1268-75.
  • 8 Comerota AJ. The ATTRACT trial: Rationale for early intervention for iliofemoral DVT. Perspect Vasc Surg Endovasc Ther 2009;21:221-4.
  • 9 Enden T, Sandvik L, Kløw NE, Hafsahl G, Holme PA, Holmen LO, et al. Catheter-directed Venous thrombolysis in acute iliofemoral vein thrombosis - the CaVenT study: Rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771). Am Heart J 2007;154:808-14.
  • 10 Kim JY, Choi D, Guk Ko Y, Park S, Jang Y, Lee do Y. Percutaneous treatment of deep vein thrombosis in May-Thurner syndrome. Cardiovasc Intervent Radiol 2006;29:571-5.
  • 11 Baekgaard N, Broholm R, Just S, Jørgensen M, Jensen LP. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg 2010;39:112-7.
  • 12 Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: A clinical review. Can J Surg 1993;36:359-64.
  • 13 Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997;82:423-8.
  • 14 Tick LW, Kramer MH, Rosendaal FR, Faber WR, Doggen CJ. Risk factors for post-thrombotic syndrome in patients with a first deep venous thrombosis. J Thromb Haemost 2008;6:2075-81.
  • 15 Grunwald MR, Hofmann LV. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis. J Vasc Interv Radiol 2004;15:347-52.
  • 16 Swischuk JL, Smouse HB. Differentiating pharmacologic agents used in catheter-directed thrombolysis. Semin Intervent Radiol 2005;22:121-9.